Effects of Rifampin on the Pharmacokinetics of Nilotinib in Healthy Subjects

NCT00418756 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
12
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Novartis Pharmaceuticals